Trial Profile
A Randomized, Double-blind, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating HBeAg Positive Chronic Hepatitis B Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Pharmacodynamics; Therapeutic Use
- 31 Mar 2019 Status changed from active, no longer recruiting to completed.
- 04 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Mar 2011 New trial record